A detailed history of Bridgeway Capital Management, LLC transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 132,700 shares of VOR stock, worth $132,700. This represents 0.01% of its overall portfolio holdings.

Number of Shares
132,700
Previous 162,700 18.44%
Holding current value
$132,700
Previous $366,000 14.21%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.8 - $2.85 $54,000 - $85,500
-30,000 Reduced 18.44%
132,700 $314,000
Q3 2023

Nov 14, 2023

BUY
$2.1 - $3.35 $131,250 - $209,375
62,500 Added 62.38%
162,700 $344,000
Q4 2022

Feb 14, 2023

BUY
$3.98 - $7.43 $82,784 - $154,544
20,800 Added 26.2%
100,200 $666,000
Q3 2022

Nov 14, 2022

BUY
$4.36 - $5.52 $43,600 - $55,199
10,000 Added 14.41%
79,400 $316,000
Q2 2022

Aug 15, 2022

BUY
$3.89 - $6.44 $269,966 - $446,936
69,400 New
69,400 $345,000

Others Institutions Holding VOR

About Vor Biopharma Inc.


  • Ticker VOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,056,300
  • Market Cap $38.1M
  • Description
  • Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...
More about VOR
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.